Multi-Functional Small Molecules as Anti-Proliferative Agents
申请人:Cai Xiong
公开号:US20080221132A1
公开(公告)日:2008-09-11
The present invention relates to the compositions, methods, and applications of a novel approach to selective inhibition of several cellular or molecular targets with a single small molecule. More specifically, the present invention relates to multi-functional small molecules wherein one functionality is capable of inhibiting histone deacetylases (HDAC) and the other functionality is capable of inhibiting a different cellular or molecular pathway involved in aberrant cell proliferation, differentiation or survival.
DNA METHYL TRANSFERASE INHIBITORS CONTAINING A ZINC BINDING MOIETY
申请人:Cai Xiong
公开号:US20080234355A1
公开(公告)日:2008-09-25
The present invention relates to inhibitors of DNMT containing zinc moiety derivatives that have enhanced or unique properties as inhibitors of DNA methyl transferases (DNMT) and their use in the treatment of DNMT related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
[EN] MULTI-FUNCTIONAL SMALL MOLECULES AS ANTI-PROLIFERATIVE AGENTS<br/>[FR] PETITES MOLÉCULES MULTIFONCTIONNELLES SERVANT D'AGENTS ANTI-PROLIFÉRATIFS
申请人:CURIS INC
公开号:WO2008033747A3
公开(公告)日:2008-12-04
MULTI-FUNCTIONAL SMALL MOLECULES AS ANTI-PROLIFERATIVE AGENTS
申请人:Curis, Inc.
公开号:EP2061772A2
公开(公告)日:2009-05-27
[EN] DNA METHYL TRANSFERASE INHIBITORS CONTAINING A ZINC BINDING MOIETY<br/>[FR] INHIBITEURS DE L'ADN MÉTHYLE-TRANSFERASE (DNMT) CONTENANT UN GROUPE DE LIAISON AU ZINC
申请人:CURIS INC
公开号:WO2008033744A2
公开(公告)日:2008-03-20
[EN] The present invention relates to inhibitors of DNMT containing zinc moiety derivatives that have enhanced or unique properties as inhibitors of DNA methyl transferases (DNMT) and their use in the treatment of DNMT related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors. [FR] L'invention concerne des inhibiteurs de DNMT contenant des dérivés comportant un groupe de liaison au zinc. Ces inhibiteurs présentent des propriétés accrues ou uniques en tant qu'inhibiteurs d'ADN méthyle-transferases (DNMT). L'invention concerne également un procédé d'utilisation de ces inhibiteurs visant à traiter des maladies associées à DNMT et des troubles comme le cancer. Les dérivés susmentionnés peuvent également servir d'inhibiteurs de l'histone désacétylase (HDAC).